Radiopharmaceutical therapy (RPT) combined with external beam radiotherapy (EBRT) is emerging as a powerful approach in prostate cancer treatment. Historically rooted in early 89Sr trials, this ...

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

The Nuclear Medicine Global Initiative was formed in 2012 by 13 international organizations to promote human health by advancing the field of nuclear medicine and molecular imaging by supporting the ...

See an invited perspective on this article on page 1412. Tumor growth and spread are determined not only by cancer cells but also by the nonmalignant constituents of the malignant lesion, which are ...

Journal of Nuclear Medicine January 2026, jnumed.125.270906; DOI: https://doi.org/10.2967/jnumed.125.270906 ...

Myocardial perfusion imaging has limited sensitivity for the detection of high-risk coronary artery disease (CAD). We tested the hypothesis that a normal coronary flow reserve (CFR) would be helpful ...

Complaints of a dry mouth (xerostomia) and sialoadenitis are frequent side effects of radioiodine treatment in differentiated thyroid cancer (DTC) patients. However, detailed prospective data on ...

TO THE EDITOR: Radiopharmaceuticals for PET imaging are regulated as drugs by the U.S. Food and Drug Administration (FDA) through several offices within the Center for Drug Evaluation and Research, ...

Journal of Nuclear Medicine December 2025, jnumed.125.270770; DOI: https://doi.org/10.2967/jnumed.125.270770 ...

TO THE EDITOR: In the article written by Veit-Haibach et al. (1), the authors highlight the growing interest in the use of radiopharmaceuticals for both diagnosis and treatment, with a significant ...